Oregon Public Employees Retirement Fund’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $213K | Sell |
9,411
-458
| -5% | -$10.2K | ﹤0.01% | 1410 |
|
|
2025
Q4 | $255K | Sell |
9,869
-300
| -3% | -$7.13K | ﹤0.01% | 1371 |
|
|
2025
Q3 | $262K | Sell |
10,169
-400
| -4% | -$9.82K | ﹤0.01% | 1343 |
|
|
2025
Q2 | $253K | Sell |
10,569
-40
| -0.4% | -$1.01K | ﹤0.01% | 1337 |
|
|
2025
Q1 | $264K | Sell |
10,609
-300
| -3% | -$7.18K | 0.01% | 1318 |
|
|
2024
Q4 | $206K | Hold |
10,909
| – | – | ﹤0.01% | 1403 |
|
|
2024
Q3 | $164K | Sell |
10,909
-400
| -4% | -$6.84K | ﹤0.01% | 1453 |
|
|
2024
Q2 | $324K | Sell |
11,309
-1,100
| -9% | -$31.3K | 0.01% | 1274 |
|
|
2024
Q1 | $363K | Sell |
12,409
-1,200
| -9% | -$36.9K | 0.01% | 1265 |
|
|
2023
Q4 | $459K | Sell |
13,609
-200
| -1% | -$5.85K | 0.01% | 1248 |
|
|
2023
Q3 | $424K | Sell |
13,809
-500
| -3% | -$18K | 0.01% | 1333 |
|
|
2023
Q2 | $573K | Sell |
14,309
-400
| -3% | -$16.5K | 0.01% | 1258 |
|
|
2023
Q1 | $600K | Sell |
14,709
-540
| -4% | -$21.5K | 0.01% | 1223 |
|
|
2022
Q4 | $589K | Buy |
15,249
+29
| +0.2% | +$1.41K | 0.01% | 1233 |
|
|
2022
Q3 | $810K | Buy |
15,220
+300
| +2% | +$16.7K | 0.01% | 1040 |
|
|
2022
Q2 | $870K | Sell |
14,920
-1,993
| -12% | -$131K | 0.01% | 880 |
|
|
2022
Q1 | $1.29M | Hold |
16,913
| – | – | 0.01% | 958 |
|
|
2021
Q4 | $1.02M | Sell |
16,913
-800
| -5% | -$44.1K | 0.01% | 1002 |
|
|
2021
Q3 | $992K | Sell |
17,713
-100
| -0.6% | -$5.76K | 0.01% | 996 |
|
|
2021
Q2 | $1.08M | Hold |
17,813
| – | – | 0.01% | 978 |
|
|
2021
Q1 | $1.25M | Buy |
17,813
+572
| +3% | +$40.9K | 0.01% | 880 |
|
|
2020
Q4 | $1.03M | Sell |
17,241
-59
| -0.3% | -$3.46K | 0.01% | 890 |
|
|
2020
Q3 | $1.04M | Buy |
17,300
+300
| +2% | +$17.4K | 0.02% | 752 |
|
|
2020
Q2 | $892K | Hold |
17,000
| – | – | 0.01% | 846 |
|
|
2020
Q1 | $570K | Hold |
17,000
| – | – | 0.01% | 961 |
|
|
2019
Q4 | $770K | Buy |
+17,000
| New | +$722K | 0.01% | 1023 |
|
Other funds holding PCRX
DPCM
VPM
VCM